Gilead launches research facility in US for new medicine development
The new research centre is part of Gilead's strategy to advance US research, development and manufacturing through 2030.
Drug Development
FDA grants RMAT designation to RiboX’s RXRG001 for xerostomia
LSTM opens $23m robotic AI lab for infection research
Novartis India acquires Pfizer brands for $132m
AtomVie opens $160m radiopharmaceutical manufacturing facility in Ontario
FDA approves AstraZeneca’s Etcamah combo for advanced breast cancer
Superluminal Medicines secures $60m to advance rare obesity therapy
Médunik and Biocodex sign exclusive agreement for Diacomit in Canada
